EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Mortality Risk Stratification for Takotsubo Syndrome: Evaluating CRP Measurement Alongside the InterTAK Prognostic Score

Loïc Faucher iD, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini-Kerth und 1 weitere

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15161 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Loïc Faucher und 12 weiteren Autor:innen. Beteiligte Einrichtung: Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, …. Hauptthemen laut MEDLINE: Takotsubo Cardiomyopathy, C-Reactive Protein, Registries. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GERCA (Groupe pour l'Enseignement, la prévention et la Recherche Cardiologique en Alsace).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis. This study aimed to evaluate the incremental prognostic utility of C-reactive protein (CRP) in conjunction with the InterTAK prognosis score for stratifying long-term mortality in Takotsubo syndrome.

Methods

A retrospective analysis was conducted from a multicentre registry encompassing 307 patients diagnosed with Takotsubo syndrome between 2008 and 2020. Patients were stratified into quartiles based on the InterTAK prognosis score. The discriminatory potential of CRP in predicting long-term mortality was assessed. The primary endpoint was defined as all-cause mortality within 1 year.

Results

A stepwise increase of CRP at discharge that corresponds to INTERTAK quartiles was observed: 9.5 mg/L (25th percentile) in the first quartile, 15.8 mg/L (median) in the second quartile, 25.3 mg/L (75th percentile) in the third quartile and 41.2 mg/L (maximum) in the fourth quartile. Receiver operating-characteristic curves analysis revealed that CRP value at discharge was predictive of 1 year mortality (area under the curve = 0.81; 95% confidence interval = 0.68–0.90) with an optimal threshold set at 33 mg/L (sensitivity: 65%; specificity: 87%). When considering the InterTAK score, the incorporation of CRP at discharge with a cut-off of 33 mg/L exhibited a significant enhancement in the prediction of 1 year mortality in ‘intermediate’ risk (25% vs. 1%; P = 0.008) or ‘very high’ risk (40% vs. 10%; P = 0.02) patients.

Conclusions

In Takotsubo syndrome, the persistence of inflammatory burden at hospital discharge emerged as an independent predictor of 1 year mortality, augmenting the predictive capacity of the conventional InterTAK prognosis score.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Takotsubo CardiomyopathyC-Reactive ProteinRegistriesHumansFemaleMaleRetrospective StudiesPrognosisRisk AssessmentAgedBiomarkersSurvival RateFollow-Up StudiesROC CurveMiddle AgedRisk FactorsGlobal Health

Stichwörter der Autor:innen

CardiomyopathyCatecholamineEndotheliumInflammationInterTAKTakotsubo syndrome

Substanzen

C-Reactive ProteinBiomarkers

Autor:innen und Institutionen

  • Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.
  • Translational Cardiovascular Medicine, CRBS, University of Strasbourg, Strasbourg, France.
  • Division of Cardiology, Yokohama City University Medical Center, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Hanoï Medical University, Hanoi, Vietnam.

ORCID-Profile: Loïc Faucher

Förderung

  • GERCA (Groupe pour l'Enseignement, la prévention et la Recherche Cardiologique en Alsace)

Zitieren

APA

Faucher, L., Matsushita, K., Kikuchi, S., Tatarcheh, T., Marchandot, B., Granier, A., Amissi, S., Trimaille, A., Jesel, L., Ohlmann, P., Hibi, K., Schini-Kerth, V., & Morel, O. (2025). Mortality Risk Stratification for Takotsubo Syndrome: Evaluating CRP Measurement Alongside the InterTAK Prognostic Score. ESC Heart Failure. https://doi.org/10.1002/ehf2.15161

Vancouver

Faucher L, Matsushita K, Kikuchi S, Tatarcheh T, Marchandot B, Granier A, et al. Mortality Risk Stratification for Takotsubo Syndrome: Evaluating CRP Measurement Alongside the InterTAK Prognostic Score. ESC Heart Failure. 2025. doi:10.1002/ehf2.15161

BibTeX
@article{Faucher2025,
  author = {Faucher, Loïc and Matsushita, Kensuke and Kikuchi, Shinnosuke and Tatarcheh, Taraneh and Marchandot, Benjamin and Granier, Amandine and Amissi, Said and Trimaille, Antonin and Jesel, Laurence and Ohlmann, Patrick and Hibi, Kiyoshi and Schini-Kerth, Valérie and Morel, Olivier},
  title = {Mortality Risk Stratification for Takotsubo Syndrome: Evaluating CRP Measurement Alongside the InterTAK Prognostic Score},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15161}
}
Kostenlos starten →